Study in Patients With Asthma
This study has been completed.
Information provided by:
First received: September 13, 2005
Last updated: November 10, 2010
Last verified: February 2008
The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control group.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Primary Purpose: Treatment
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Dey:
Primary Outcome Measures:
- Primary: The primary efficacy outcome is measure of lung function.
Secondary Outcome Measures:
- Secondary: Change in lung function will be examined as a secondary efficacy outcome, as well as vital signs, physical examination, adverse event reporting,etc.
|Study Start Date:||July 2002|
|Study Completion Date:||November 2005|
|Primary Completion Date:||October 2002 (Final data collection date for primary outcome measure)|
Contacts and Locations